Richard McGregor

Richard McGregor has extensive experience in the biopharmaceutical industry, with a focus on business development and research partnerships. Richard is currently the Director of Business Development at KBP Biosciences, a global clinical stage biopharmaceutical company. In this role, they direct the development of innovative chemical entities targeting underserved patient populations in organ protection and infectious diseases.

Prior to their current position, Richard worked as the Director of Research Partnerships at JDRF International from 2018 to 2020. Here, they oversaw the establishment of research collaborations to advance treatments for type 1 diabetes.

Richard also held various roles at GlaxoSmithKline (GSK) from 2007 to 2015. As the Director of Open Innovation, they were responsible for developing and executing external innovation strategies in the consumer healthcare R&D division. Richard also maintained strong relationships with key vendors and potential partners. Before this role, Richard served as the Associate Director of the Open Innovation Team at GSK, where they led a program to identify breakthrough technologies through external search and evaluation approaches.

Earlier in their career, Richard worked at Redpoint Bio Corp as the Director of Technology Assessment. In this role, they developed new business relationships with external partners, negotiated technology licensing agreements, and represented the company in negotiations with business and academic partners.

Overall, Richard McGregor has a strong track record in business development and research partnerships, with expertise in the biopharmaceutical industry.

Richard McGregor completed their Bachelor of Science (Honors) degree in Biochemistry from the University of Bristol from 1988 to 1991. Richard then pursued a PhD in Biochemistry and Molecular Biology from the University of Leeds, which they obtained from 1991 to 1996.